Source: CellNetix Blog

CellNetix Blog Impact of Molecular Testing on Diagnostic Accuracy and Amendment Rates in Liver Tumor Cases

CellNetix pathologist, Dr. Eric Nguyen, co-presented a poster titled "Impact of Molecular Testing on Diagnostic Accuracy and Amendment Rates in Liver Tumor Cases" at the USCAP 114th Annual Meeting in Boston, along with Dr. Xiaoqin Liu, UCSF Medical Center; Dr. Dorukhan Bahceci, Memorial Sloan Kettering Cancer Center; and Dr. Sanjay Kakar, University of California, San [...]

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
250-500
Kathleen Fondren's photo - CEO of CellNetix

CEO

Kathleen Fondren

CEO Approval Rating

89/100

Read more